Clinical Trial Update: Biomarkers in Dermal Interstitial Fluid for Early Diagnosis and Follow-up of Cardiovascular Diseases

View source ↗

Summary

This entry notes a clinical trial by Ascilion AB evaluating biomarkers in dermal interstitial fluid for early diagnosis and monitoring of cardiovascular disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: Ascilion AB | Conditions: Cardiovascular Diseases | Status: ACTIVE_NOT_RECRUITING